In-Lab Upfront Use of Tirofiban May Reduce the Occurrence of No-Reflow During Primary Percutaneous Coronary Intervention. A Pilot Randomized Study
在术中预先使用替罗非班可能降低经皮冠状动脉介入治疗期间无复流的发生率。一项初步随机研究
期刊:
影响因子:
doi:10.5935/abc.20160149
Lago, Igor Matos; Novaes, Gustavo Caires; Badran, André Vannucchi; Pavão, Rafael Brolio; Barbosa, Ricardo; Figueiredo, Geraldo Luiz de; Lima, Moysés de Oliveira Filho; Haddad, Jorge Luiz; Schmidt, André; Marin, José Antônio Neto
